NOVEN ANNOUNCES 2008 FIRST QUARTER EARNINGS RELEASE DATE |
BackMiami, FL, May 5,
2008 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced
its 2008 first quarter earnings release date. Separately, Noven also
announced an upcoming investor presentation.
On May 8, 2008, before the U.S.
market opens, Noven is scheduled to issue a press release announcing
its financial results for the quarter ended March 31, 2008. At 8:30
a.m. ET the same day, a conference call with management is scheduled
to be webcast live at www.noven.com, and thereafter a rebroadcast will
be available at the same site for at least two weeks. A taped replay
of the call will be available beginning May 8 through May 10 by calling
877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the
U.S.) and entering account number 286 and conference ID number 282673.
Noven also announced that Jeffrey F. Eisenberg, Noven’s Executive
Vice President, is scheduled to present an update on Noven’s
business and prospects at the Deutsche Bank 33rd Annual Health Care
Conference in Boston, MA on Tuesday, May 6 at 8:50 a.m. ET. The presentation
will be webcast live at www.noven.com, and a rebroadcast will be available
thereafter at the same site.
About Noven
Noven Pharmaceuticals, Inc.
is a specialty pharmaceutical company engaged in the research, development,
manufacture, marketing and sale of prescription pharmaceutical products.
Noven’s business and operations are focused in three principal
areas – transdermal drug delivery, the Novogyne joint venture,
and its Noven Therapeutics specialty pharmaceutical unit.
Contact:
|
Copyright © 2008 Noven Pharmaceuticals, Inc. All rights reserved.